{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:51:35Z","timestamp":1776275495050,"version":"3.50.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Rifampin may improve diabetic foot osteomyelitis outcomes, but its extensive drug\u2013drug interactions could hamper its use. Here, through a review of the medications prescribed to a cohort of 190 persons with diabetic foot osteomyelitis, we show that rifabutin, a rifamycin with fewer drug\u2013drug interactions, would be easier to implement in practice.<\/jats:p>","DOI":"10.1093\/ofid\/ofae582","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T10:37:38Z","timestamp":1728643058000},"source":"Crossref","is-referenced-by-count":3,"title":["High Prescription Rate of Medications With Rifampin Drug\u2013drug Interactions in Patients With Diabetic Foot Osteomyelitis: Should Rifabutin Be Included in Clinical Trials for Adjunctive Therapy?"],"prefix":"10.1093","volume":"11","author":[{"given":"Christina","family":"Mallarino-Haeger","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2207-9971","authenticated-orcid":false,"given":"Allison","family":"Watson","sequence":"additional","affiliation":[{"name":"Department of Global Health, Rollins School of Public Health, Emory University , Atlanta, Georgia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8482-8504","authenticated-orcid":false,"given":"Umnia","family":"Mahgoub","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Rollins School of Public Health, Emory University , Atlanta, Georgia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5460-8279","authenticated-orcid":false,"given":"Lily","family":"Francis","sequence":"additional","affiliation":[{"name":"Medical College of Georgia, Augusta University , Augusta, Georgia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3379-4846","authenticated-orcid":false,"given":"Maryam","family":"Heydari","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Rollins School of Public Health, Emory University , Atlanta, Georgia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muaaz","family":"Choudhary","sequence":"additional","affiliation":[{"name":"Lewis Katz School of Medicine, Temple University , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Garcia-Toca","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery, Department of Surgery, Emory University School of Medicine , Atlanta, Georgia ,","place":["USA"]},{"name":"Grady Health System , Atlanta, Georgia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1372-9696","authenticated-orcid":false,"given":"Manish","family":"Patel","sequence":"additional","affiliation":[{"name":"Grady Health System , Atlanta, Georgia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7188-4996","authenticated-orcid":false,"given":"Russell R","family":"Kempker","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia ,","place":["USA"]},{"name":"Grady Health System , Atlanta, Georgia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Fayfman","sequence":"additional","affiliation":[{"name":"Grady Health System , Atlanta, Georgia ,","place":["USA"]},{"name":"Division of Endocrinology, Metabolism, and Lipids, Emory University School of Medicine , Atlanta, Georgia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6165-7423","authenticated-orcid":false,"given":"Marcos C","family":"Schechter","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine , Atlanta, Georgia ,","place":["USA"]},{"name":"Grady Health System , Atlanta, Georgia ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"key":"2024112610420127400_ofae582-B1","doi-asserted-by":"crossref","first-page":"964","DOI":"10.2337\/dc19-1614","article-title":"Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016","volume":"43","author":"Zhang","year":"2020","journal-title":"Diabetes Care"},{"key":"2024112610420127400_ofae582-B2","doi-asserted-by":"crossref","first-page":"e0239236","DOI":"10.1371\/journal.pone.0239236","article-title":"Risk factors for lower extremity amputation in patients with diabetic foot ulcers: a meta-analysis","volume":"15","author":"Lin","year":"2020","journal-title":"PLoS One"},{"key":"2024112610420127400_ofae582-B3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2337\/dc18-1380","article-title":"Resurgence of diabetes-related nontraumatic lower-extremity amputation in the young and middle-aged adult US population","volume":"42","author":"Geiss","year":"2019","journal-title":"Diabetes Care"},{"key":"2024112610420127400_ofae582-B4","doi-asserted-by":"crossref","first-page":"e1916003","DOI":"10.1001\/jamanetworkopen.2019.16003","article-title":"Adjunctive rifampin therapy for diabetic foot osteomyelitis in the Veterans Health Administration","volume":"2","author":"Wilson","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2024112610420127400_ofae582-B5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/1472-6963-10-193","article-title":"Variation in antibiotic treatment for diabetic patients with serious foot infections: a retrospective observational study","volume":"10","author":"Fincke","year":"2010","journal-title":"BMC Health Serv Res"},{"key":"2024112610420127400_ofae582-B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/ciad527","article-title":"IWGDF\/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF\/IDSA 2023)","volume":"79","author":"Senneville","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2024112610420127400_ofae582-B7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12879-019-4751-3","article-title":"A multicenter randomized placebo controlled trial of rifampin to reduce pedal amputations for osteomyelitis in veterans with diabetes (VA INTREPID)","volume":"20","author":"Bessesen","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"Suppl 1","key":"2024112610420127400_ofae582-B8","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1002\/dmrr.836","article-title":"Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment","volume":"24","author":"Berendt","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"2024112610420127400_ofae582-B9","article-title":"Rifamycin drug-drug interactions. A guide for primary care providers treating latent tuberculosis infection","author":"State of California Department of Public Health, Tuberculosis Control Branch (CDPH), the Rutgers Ernest Mario School of Pharmacy (EMSOP), the Rutgers Global Tuberculosis Institute (GTBI), and the Curry International Tuberculosis Center (CITC)","year":"2022"},{"key":"2024112610420127400_ofae582-B10","doi-asserted-by":"crossref","first-page":"e00959-19","DOI":"10.1128\/AAC.00959-19","article-title":"In vitro activity of rifampin, rifabutin, rifapentine, and rifaximin against planktonic and biofilm states of staphylococci isolated from periprosthetic joint infection","volume":"63","author":"Albano","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2024112610420127400_ofae582-B11","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/jac\/dkab486","article-title":"Rifabutin versus rifampicin bactericidal and antibiofilm activities against clinical strains of Staphylococcus spp. isolated from bone and joint infections","volume":"77","author":"Thill","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2024112610420127400_ofae582-B12","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/infdis\/jiaa401","article-title":"Novel use of rifabutin and rifapentine to treat methicillin-resistant Staphylococcus aureus in a rat model of foreign body osteomyelitis","volume":"222","author":"Karau","year":"2020","journal-title":"J Infect Dis"},{"key":"2024112610420127400_ofae582-B13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/antibiotics9060326","article-title":"Rifabutin use in Staphylococcus biofilm infections: a case series","volume":"9","author":"Doub","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"2024112610420127400_ofae582-B14","doi-asserted-by":"crossref","first-page":"e0038422","DOI":"10.1128\/spectrum.00384-22","article-title":"A case series of rifabutin use in staphylococcal prosthetic infections","volume":"10","author":"Monk","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2024112610420127400_ofae582-B15","doi-asserted-by":"crossref","first-page":"107516","DOI":"10.1016\/j.jdiacomp.2019.107516","article-title":"Evaluation of a comprehensive diabetic foot ulcer care quality model","volume":"34","author":"Schechter","year":"2020","journal-title":"J Diabetes Complications"},{"key":"2024112610420127400_ofae582-B16","doi-asserted-by":"crossref","first-page":"ofaa393","DOI":"10.1093\/ofid\/ofaa393","article-title":"Percutaneous bone biopsy for diabetic foot osteomyelitis: a systematic review and meta-analysis","volume":"7","author":"Schechter","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2024112610420127400_ofae582-B17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2024112610420127400_ofae582-B18"},{"key":"2024112610420127400_ofae582-B19","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"2024112610420127400_ofae582-B20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ajh.21917","article-title":"Prevalence of clinical venous thromboembolism in the USA: current trends and future projections","volume":"86","author":"Deitelzweig","year":"2011","journal-title":"Am J Hematol"},{"key":"2024112610420127400_ofae582-B21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00125-006-0491-1","article-title":"High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study","volume":"50","author":"Prompers","year":"2007","journal-title":"Diabetologia"},{"key":"2024112610420127400_ofae582-B22","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/j.1538-7836.2010.03925.x","article-title":"Potentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y12 receptor blockade and inhibition of platelet aggregation after clopidogrel","volume":"8","author":"Judge","year":"2010","journal-title":"J Thromb Haemost"},{"key":"2024112610420127400_ofae582-B23","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1093\/ajhp\/zxab210","article-title":"Cefazolin and rifampin: a coagulopathy-inducing combination","volume":"78","author":"Castillo Almeida","year":"2021","journal-title":"Am J Health Syst Pharm"},{"key":"2024112610420127400_ofae582-B24","doi-asserted-by":"crossref","first-page":"e1219","DOI":"10.1097\/IPC.0000000000001219","article-title":"Outpatient parenteral antibiotic therapy for diabetic foot osteomyelitis in an uninsured and underinsured cohort","volume":"31","author":"Schechter","year":"2023","journal-title":"Infect Dis Clin Pract"},{"key":"2024112610420127400_ofae582-B25","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jvs.2023.07.020","article-title":"The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes mellitus and a foot ulcer","volume":"78","author":"Fitridge","year":"2023","journal-title":"J Vasc Surg"},{"key":"2024112610420127400_ofae582-B26","author":"FDA"},{"key":"2024112610420127400_ofae582-B27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/d41573-021-00002-0","article-title":"2020 FDA drug approvals","volume":"20","author":"Mullard","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"2024112610420127400_ofae582-B28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s15010-015-0773-y","article-title":"Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections","volume":"43","author":"Curis","year":"2015","journal-title":"Infection"},{"key":"2024112610420127400_ofae582-B29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jinf.2015.03.013","article-title":"Dramatic reduction of clindamycin serum concentration in staphylococcal osteoarticular infection patients treated with the oral clindamycin-rifampicin combination","volume":"71","author":"Bernard","year":"2015","journal-title":"J Infect"},{"key":"2024112610420127400_ofae582-B30","doi-asserted-by":"crossref","first-page":"106885","DOI":"10.1016\/j.ijantimicag.2023.106885","article-title":"Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections","volume":"62","author":"Goulenok","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"2024112610420127400_ofae582-B31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1592\/phco.27.3.476","article-title":"Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid and rifampin","volume":"27","author":"Gebhart","year":"2007","journal-title":"Pharmacotherapy"},{"key":"2024112610420127400_ofae582-B32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000445194","article-title":"Decreased linezolid serum concentrations in three critically ill patients: clinical case studies of a potential drug interaction between linezolid and rifampicin","volume":"98","author":"Blassmann","year":"2016","journal-title":"Pharmacology"},{"key":"2024112610420127400_ofae582-B33","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1086\/521894","article-title":"Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis","volume":"45","author":"Nijland","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2024112610420127400_ofae582-B34","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/jac\/dkw024","article-title":"Rifabutin: where do we stand in 2016?","volume":"71","author":"Crabol","year":"2016","journal-title":"J Antimicrob Chemother"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofae582\/59719094\/ofae582.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/11\/ofae582\/60750924\/ofae582.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/11\/ofae582\/60750924\/ofae582.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T10:42:21Z","timestamp":1732617741000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae582\/7818262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae582","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,10,11]]},"article-number":"ofae582"}}